HCV

February 19, 2015February 19, 2015

Liver Cirrhosis Found More Prevalent Than Previous Estimates

Hepatitis C, News

A recent study evaluated the incidence of cirrhosis in the general American population. The study entitled “The Epidemiology of Cirrhosis in the United States: A Population-based Study” was published in ... Read more

February 13, 2015February 13, 2015

Study Reveals Hepatitis C Lacks Equal Attention Than HIV/AIDS or Ebola Yet is More Prevalent

Hepatitis B, Hepatitis C, News

A new study on Hepatitis C virus in West Africa entitled “High Frequency of Active HCV Infection Among Seropositive Cases in West Africa and Evidence for Multiple Transmission Pathways” was ... Read more

February 11, 2015February 13, 2015

AbbVie Reports Phase 3 Data on Ombitasvir-Paritaprevir-Ritonavir Therapy for Hepatitis C in Japan

Hepatitis C, News

AbbVie announced findings from a Phase 3 clinical trial (GIFT-I (M13-004)) for its new oral, ribavirin (RBV)-free antiviral treatment with a fixed-dose combination of paritaprevir/ritonavir (150/100 mg) with ombitasvir (25 mg), ... Read more

February 2, 2015February 2, 2015

Sofosbuvir-Ribavirin Prevent HCV Recurrence After Transplantation

Hepatitis C, News

Two new studies on the hepatitis C virus entitled “Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection after Liver Transplantation: An Open-Label Study” and “Sofosbuvir and Ribavirin for Treatment of ... Read more

January 12, 2015January 12, 2015

HIV-HCV Co-Infection Does Not Cause Neurocognitive Impairment According to Study

News

HIV patients are not at risk of neurocognitive impairment from a co-infection of hepatitis C virus (HCV), according to a study, titled, “Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people” conducted ... Read more

January 8, 2015January 8, 2015

Awareness May Prevent Losing HCV Patients in Health-Care System

Hepatitis C, News

Patients suffering from hepatitis C virus (HCV) infection, at times, end up lost between separate stages of health care for the management of their disease, according to a recent study ... Read more

January 5, 2015January 5, 2015

PCORI Board Grants $50 Million Funding for Hepatitis C Clinical Effectiveness Research

Hepatitis C, News

The Patient-Centered Outcomes Research Institute (PCORI) has granted $50 million for the development of four comparative clinical effectiveness research (CER) studies dedicated to the diagnosis and treatment of hepatitis C virus (HCV) ... Read more

January 2, 2015January 2, 2015

Bristol-Myers Foundation Funds HBV, HCV Projects in China and India

Hepatitis B, Hepatitis C, News

Bristol-Myers Squibb Foundation recently granted nine awards to research projects dedicated to studying and fighting hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in China and India. The foundation has ... Read more

December 11, 2014December 20, 2014

Simeprevir as Effective as Standard Hepatitis C Therapy with Telaprevir

Hepatitis C, News

Treating patients who suffer from chronic Hepatitis C virus infection (HCV) with once a day protease inhibitor simeprevir along with interferon and ribavirin has been demonstrated to be as effective as administering them with telaprevir with ... Read more

November 21, 2014November 21, 2014

First Oral Combination Drug for Hep C Approved in Europe

Hepatitis C, News

Gilead Sciences, Inc. recently announced that the European Commission has finally granted marketing authorization for their novel hepatitis C treatment Harvoni® (ledipasvir 90 mg/sofosbuvir 400 mg), which is the first and only once-a-day ... Read more